Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial.
Sign Up to like & getrecommendations! Published in 2022 at "Drug discoveries & therapeutics"
DOI: 10.5582/ddt.2022.01068
Abstract: The aim of this study was to determine the efficacy and safety of ciclesonide in the treatment of novel coronavirus disease 2019 (COVID-19) as gauged by pneumonia progression. This multi-center, open-label randomized trial was conducted… read more here.
Keywords: impact inhaled; ciclesonide asymptomatic; trial; covid ... See more keywords